Latest news
Loading news…
Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
9
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Ness Ziona, HaMerkaz, Israel
Key People at Enlivex Therapeutics
Project Lead
CFO
Founder and Chief Scientific Officer
Chief Executive Officer
9
professional contacts at Enlivex Therapeutics
Contact execs at Enlivex Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Enlivex Therapeutics
Loading news…
FAQs about Enlivex Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.